Treprostinil
Platelet Aggregation Inhibitors Excl. Heparin
Sold as Trepulmix · REMODULIN
- Drug class
- Platelet Aggregation Inhibitors Excl. Heparin
- Availability
- See label
- Routes
- Subcutaneous, Intravenous
- Markets covered
- 3
- Products on record
- 27
Overview
Treprostinil is an active pharmaceutical ingredient in the Platelet Aggregation Inhibitors Excl. Heparin group (B01AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 14 | March 13, 2026 |
| CA Canada | Health Canada | 12 | May 20, 2026 |
| EU European Union | EMA | 1 | July 31, 2025 |
GBUnited Kingdom· MHRA
14 products
Uses
Treatment of idiopathic or heritable pulmonary arterial hypertension (PAH) to improve exercise tolerance and symptoms of the disease in patients classified as New York Heart Association (NYHA) functional class III.
How to take
CACanada· Health Canada
12 products
Uses
AND CLINICAL USE ............................................................................. 3 CONTRAINDICATIONS ................................................................................................... 3 WARNINGS AND PRECAUTIONS .................................................................................
4 ADVERSE REACTIONS ................................................................................................... 6 DRUG INTERACTIONS .................................................................................................
11 DOSAGE AND ADMINISTRATION ............................................................................. 12 OVERDOSAGE ................................................................................................................
17 ACTION AND CLINICAL PHARMACOLOGY ............................................................ 17 STORAGE AND STABILITY ......................................................................................... 20 SPECIAL HANDLING INSTRUCTIONS .......................................................................
EUEuropean Union· EMA
1 product
Uses
Trepulmix is indicated for the treatment of adult patients with WHO Functional Class (FC) III or IV and: - inoperable chronic thromboembolic pulmonary hypertension (CTEPH), or - persistent or recurrent CTEPH after surgical treatment to improve exercise capacity.
How to take
Drug interactions
Known interactions involving Treprostinil. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 299. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL085530664 · revised August 22, 2025
- [2]Health Canada (DPD) · 02523841 · revised July 24, 2025
- [3]European Medicines Agency · EMEA/H/C/005207 · revised July 31, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.